CRP P P P
n median (q1 / q3)
Gender Gender <0.001 ᵘ <0.001 ᵘ <0.001 ᵘ
Female 397 35.4 (11.3 / 82.9)
Male 566 73.55 (20.5 / 131)
Lung density Lung density <0.001 ᵏ <0.001 ᵏ <0.001 ᵏ
Mild involvement 403 a 41.7 (16.3 / 84.6) p(a-b)<0.001 p(a-b)<0.001 p(a-b)<0.001
Moderate involvement 212 b 79.45 (32.65 / 131.5) a p(a-c)<0.001 p(a-c)<0.001 p(a-c)<0.001
Severe involvement 145 c 138 (79.4 / 204) ab p(b-c)<0.001 p(b-c)<0.001 p(b-c)<0.001
Lung radiography Lung radiography <0.001 ᵏ <0.001 ᵏ <0.001 ᵏ
Typical 670 a 72.95 (22.5 / 125) cd p(a-b)=0.186 p(b-c)=0.999 p(b-c)=0.999
Partially significant findings 89 b 56.8 (21.4 / 93.6) d p(a-c)=0.029 p(b-d)<0.001 p(b-d)<0.001
Atypical findings 39 c 34.3 (13.9 / 79.3) p(a-d)<0.001 p(c-d)=0.073 p(c-d)=0.073
Negative 165 d 8.9 (3.29 / 49.5)
Course of Disease Course of Disease <0.001 ᵏ <0.001 ᵏ <0.001 ᵏ
No complication 299 a 14.6 (5.22 / 55.3) p(a-b)<0.001 p(b-c)=0.189 p(b-c)=0.189
Mild-Moderate Course 347 b 64.1 (19.6 / 110) a p(a-c)<0.001 p(b-d)<0.001 p(b-d)<0.001
Severe Course 101 c 81.3 (33.4 / 138) a p(a-d)<0.001 p(c-d)=0.139 p(c-d)=0.139
Mortal 216 d 102.5 (52 / 170.5) ab
Complication Complication <0.001 ᵘ <0.001 ᵘ <0.001 ᵘ
Absent 668 41.85 (11 / 101.8)
Present 295 79.9 (28.9 / 134)
Comorbidity Comorbidity <0.001 ᵘ <0.001 ᵘ <0.001 ᵘ
Absent 399 32.42 (7.1 / 95.1)
Present 564 70.65 (22.3 / 117.5)
Complaint Complaint <0.001 ᵘ <0.001 ᵘ <0.001 ᵘ
Absent 109 10.6 (4.09 / 31)
Present 854 67.4 (19.6 / 118)
Additional respiratory support Additional respiratory support <0.001 ᵘ <0.001 ᵘ <0.001 ᵘ
Absent 670 34.3 (10.2 / 92.2)
Present 290 100.8 (44.6 / 165)
Intensive Care Intensive Care <0.001 ᵘ <0.001 ᵘ <0.001 ᵘ
Absent 606 31.05 (8.94 / 86.4)
Present 356 95.1 (41.8 / 156.7)
r
Age Age 963 0.305 <0.001 ˢ <0.001 ˢ <0.001 ˢ
Follow-up time Follow-up time 963 0.118 <0.001 ˢ <0.001 ˢ <0.001 ˢ
PCR (+) to Discharge (Days) PCR (+) to Discharge (Days) 963 0.193 <0.001 ˢ <0.001 ˢ <0.001 ˢ
Chest CT SS Chest CT SS 760 0.445 <0.001 ˢ <0.001 ˢ <0.001 ˢ
Leucocyte Leucocyte 962 0.367 <0.001 ˢ <0.001 ˢ <0.001 ˢ
Lymphocyte Lymphocyte 961 -0.367 <0.001 ˢ <0.001 ˢ <0.001 ˢ
Neutrophil Neutrophil 957 0.474 <0.001 ˢ <0.001 ˢ <0.001 ˢ
NLR NLR 956 0.581 <0.001 ˢ <0.001 ˢ <0.001 ˢ
D-Dimer (mg/dL) D-Dimer (mg/dL) 724 0.480 <0.001 ˢ <0.001 ˢ <0.001 ˢ
Ferritin (mg/dL) Ferritin (mg/dL) 860 0.539 <0.001 ˢ <0.001 ˢ <0.001 ˢ
ᶸ Mann-Whitney U Test (Monte Carlo), ᵏ Kruskal Wallis Test (Monte Carlo), Post Hoc Test: Dunn’s Test ˢ Spearman’s rho Test, r: Correlation Coefficient, q1: percentile 25, q3: percentile 75, abcd expresses significance by groups. PCR= Polymerase chain reaction, CT SS= Computed Tomography severity score, NLR= Neutrophil to Lmyphocyte ratio ᶸ Mann-Whitney U Test (Monte Carlo), ᵏ Kruskal Wallis Test (Monte Carlo), Post Hoc Test: Dunn’s Test ˢ Spearman’s rho Test, r: Correlation Coefficient, q1: percentile 25, q3: percentile 75, abcd expresses significance by groups. PCR= Polymerase chain reaction, CT SS= Computed Tomography severity score, NLR= Neutrophil to Lmyphocyte ratio ᶸ Mann-Whitney U Test (Monte Carlo), ᵏ Kruskal Wallis Test (Monte Carlo), Post Hoc Test: Dunn’s Test ˢ Spearman’s rho Test, r: Correlation Coefficient, q1: percentile 25, q3: percentile 75, abcd expresses significance by groups. PCR= Polymerase chain reaction, CT SS= Computed Tomography severity score, NLR= Neutrophil to Lmyphocyte ratio ᶸ Mann-Whitney U Test (Monte Carlo), ᵏ Kruskal Wallis Test (Monte Carlo), Post Hoc Test: Dunn’s Test ˢ Spearman’s rho Test, r: Correlation Coefficient, q1: percentile 25, q3: percentile 75, abcd expresses significance by groups. PCR= Polymerase chain reaction, CT SS= Computed Tomography severity score, NLR= Neutrophil to Lmyphocyte ratio ᶸ Mann-Whitney U Test (Monte Carlo), ᵏ Kruskal Wallis Test (Monte Carlo), Post Hoc Test: Dunn’s Test ˢ Spearman’s rho Test, r: Correlation Coefficient, q1: percentile 25, q3: percentile 75, abcd expresses significance by groups. PCR= Polymerase chain reaction, CT SS= Computed Tomography severity score, NLR= Neutrophil to Lmyphocyte ratio ᶸ Mann-Whitney U Test (Monte Carlo), ᵏ Kruskal Wallis Test (Monte Carlo), Post Hoc Test: Dunn’s Test ˢ Spearman’s rho Test, r: Correlation Coefficient, q1: percentile 25, q3: percentile 75, abcd expresses significance by groups. PCR= Polymerase chain reaction, CT SS= Computed Tomography severity score, NLR= Neutrophil to Lmyphocyte ratio ᶸ Mann-Whitney U Test (Monte Carlo), ᵏ Kruskal Wallis Test (Monte Carlo), Post Hoc Test: Dunn’s Test ˢ Spearman’s rho Test, r: Correlation Coefficient, q1: percentile 25, q3: percentile 75, abcd expresses significance by groups. PCR= Polymerase chain reaction, CT SS= Computed Tomography severity score, NLR= Neutrophil to Lmyphocyte ratio